Medtronic’s Steve Oesterle said in 2014 that the next great competitors his company won’t be Boston Scientific or St. Jude Medical but tech giants like Google. Stockpiled with cash and willing to take on the biggest healthcare problems, Google is both pushing medtech into deeper blue ocean and forging a path for a new era of innovation.
Through its high profile partnerships in the diabetes space with recent partnerships in the diabetes space with companies like DexCom, Sanolfi or its robotic surgery efforts with Johnson & Johnson, Google is signaling that it believes the future of medtech innovation will be forged through strategic partnerships with companies outside of the industry.
While this paradigm is not new in biotech and pharmaceuticals, convergence is still new to medtech. However, the industry must continue look for new pathways to expand care without sacrificing quality.
In this mini “hackathon” (A 2-hour brainstorming and networking workshop) led by experts from MPR Product Development and Halloran Consultants, we will:
· What every medtech company needs to know about products liability litigation
· M&A trends from the perspective of both acquirer and seller
· IP protection is key to a successful exit